37 Results

People

  1. Divgi
    Divgi
  2. Finn
    Finn
  3. Larson
    Larson
  4. Old
    Old
  5. Scott
    Scott
  6. Welt
    Welt
  7. Graham
    Graham
  8. Scheinberg
    Scheinberg
  9. Pandit-Taskar
    Pandit-Taskar
  10. Sgouros
    Sgouros

Groups

  1. Molecular Imaging and Therapy Service (32)
  2. Radiology, Department of (32)
  3. GSK Faculty (31)
  4. Molecular Pharmacology and Chemistry Program Faculty (31)
  5. Sloan Kettering Institute Faculty (31)
  6. Department of Medicine (20)
  7. Medical Physics (13)
  8. Hematologic Malignancies, Division of (12)
  9. Solid Tumor Oncology Division (12)
  10. Center for Hematologic Malignancies (9)
  1. "aged"
  2. "Chaitanya Divgi"
Formats
  1. Journal Article (36)
  2. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (32)
  2. Radiology, Department of (32)
  3. GSK Faculty (31)
  4. Molecular Pharmacology and Chemistry Program Faculty (31)
  5. Sloan Kettering Institute Faculty (31)
  6. Department of Medicine (20)

More Groups

People
  1. Chaitanya Divgi (37)
  2. Steven Larson (30)
  3. Ronald Finn (21)
  4. Lloyd Old (17)
  5. Andrew Scott (11)
  6. Sydney Welt (9)

More People

Years
  1. 2011 (1)
  2. 2010 (1)
  3. 2008 (1)
  4. 2007 (5)
  5. 2005 (1)
  6. 2004 (1)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Clinical Cancer Research (7)
  3. Journal of Nuclear Medicine (7)
  4. Blood (2)
  5. Cancer (2)
  6. British Journal of Clinical Pharmacology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (7)
  3. Society of Nuclear Medicine (7)
  4. Elsevier Inc. (3)
  5. Wiley Blackwell (3)
  6. American Society of Hematology (2)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • International Atomic Energy Agency-Sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: Results with special emphasis on prognostic value of dosimetric study
    Journal Article

    Bernal, P.; Raoul, J. L.; Stare, J.; Sereegotov, E.; Sundram, F. X.; Kumar, A.; Jeong, J. M.; Pusuwan, P.; Divgi, C.; Zanzonico, P.; more...
    Seminars in Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: A pilot trial testing two dose levels
    Journal Article

    Krug, L. M.; Milton, D. T.; Jungbluth, A. A.; Chen, L. C.; Quaia, E.; Pandit-Taskar, N.; Nagel, A.; Jones, J.; Kris, M. G.; Finn, R.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma
    Journal Article

    Iwamoto, F. M.; Schwartz, J.; Pandit-Taskar, N.; Peak, S.; Divgi, C. R.; Zelenetz, A. D.; Humm, J.; Abrey, L. E.
    Cancer (2007)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save
  • Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: Results of an IAEA-sponsored multination study
    Journal Article

    Bernal, P.; Raoul, J. L.; Vidmar, G.; Sereegotov, E.; Sundram, F. X.; Kumar, A.; Jeong, J. M.; Pusuwan, P.; Divgi, C.; Zanzonico, P.; more...
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
    Journal Article

    Morris, M. J.; Divgi, C. R.; Pandit-Taskar, N.; Batraki, M.; Warren, N.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase I clinical trial with fractionated radioimmunotherapy using (131)I-labeled chimeric G250 in metastatic renal cancer
    Journal Article

    Divgi, C. R.; O'Donoghue, J. A.; Welt, S.; O'Neel, J.; Finn, R.; Motzer, R. J.; Jungbluth, A.; Hoffman, E.; Ritter, G.; Larson, S. M.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save